erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Acneiform Eruptions D017486 3 associated lipids
Pityriasis Lichenoides D017514 2 associated lipids
Pityriasis Rosea D017515 3 associated lipids
Lung Diseases, Interstitial D017563 5 associated lipids
Retropharyngeal Abscess D017703 2 associated lipids
Community-Acquired Infections D017714 8 associated lipids
Granuloma, Pyogenic D017789 2 associated lipids
Limb Deformities, Congenital D017880 4 associated lipids
Tuberculosis, Multidrug-Resistant D018088 6 associated lipids
Adrenocortical Carcinoma D018268 4 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Lymphoma, B-Cell, Marginal Zone D018442 1 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Gastroparesis D018589 2 associated lipids
Arthralgia D018771 8 associated lipids
Abdominal Abscess D018784 2 associated lipids
Sepsis D018805 11 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Dermatitis, Perioral D019557 4 associated lipids
Postoperative Nausea and Vomiting D020250 1 associated lipids
Enterocolitis, Necrotizing D020345 3 associated lipids
Epidural Abscess D020802 1 associated lipids
Neuroaspergillosis D020953 2 associated lipids
Communicable Diseases, Emerging D021821 3 associated lipids
Pelvic Infection D034161 1 associated lipids
Acalculous Cholecystitis D042101 3 associated lipids
Ileus D045823 3 associated lipids
Desulfovibrionaceae Infections D045824 5 associated lipids
Moraxellaceae Infections D045828 3 associated lipids
Pyloric Stenosis, Hypertrophic D046248 2 associated lipids
Micronuclei, Chromosome-Defective D048629 33 associated lipids
Seroma D049291 2 associated lipids
Granulomatosis, Orofacial D051261 2 associated lipids
Kidney Diseases, Cystic D052177 3 associated lipids
Pneumonia, Ventilator-Associated D053717 1 associated lipids
Atrioventricular Block D054537 1 associated lipids
Acute Lung Injury D055371 33 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Occupational Injuries D060051 1 associated lipids
Vagus Nerve Injuries D061223 1 associated lipids
Drug-Related Side Effects and Adverse Reactions D064420 3 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Watanabe M et al. Role of CYP3A in bromperidol metabolism in rat in vitro and in vivo. 1999 Xenobiotica pmid:10553724
Zallen RD and Curry JT A study of antibiotic usage in compound mandibular fractures. 1975 J Oral Surg pmid:1055204
Jobe DA et al. Detection of borreliacidal antibodies in Lyme borreliosis patient sera containing antimicrobial agents. 1999 Clin. Diagn. Lab. Immunol. pmid:10548588
Netherwood T et al. Probiotics shown to change bacterial community structure in the avian gastrointestinal tract. 1999 Appl. Environ. Microbiol. pmid:10543832
Aoki Y and Kao PN Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells. 1999 Antimicrob. Agents Chemother. pmid:10543746
Maeda K et al. [A case of common variable immunodeficiency that responded to long-term erythromycin chemotherapy]. 1999 Nihon Kokyuki Gakkai Zasshi pmid:10540836
Tobback K et al. Micellar electrokinetic capillary chromatography of macrolide antibiotics. Separation of tylosin, erythromycin and their related substances. 1999 J Chromatogr A pmid:10536850
Nicholas KC et al. Periadenitis mucosa necrotica recurrens. 1975 J Oral Surg pmid:1053656
Schmidtke LM and Carson J Induction, characterisation and pathogenicity in rainbow trout Oncorhynchus mykiss (Walbaum) of Lactococcus garvieae L-forms. 1999 Vet. Microbiol. pmid:10535774
Janier M [Syphilis (except congenital syphilis)]. 1999 Aug-Sep Ann Dermatol Venereol pmid:10530355
Sato A et al. Effects of organic anions and vinblastine on biliary excretion of erythromycin in rats. 1999 Pharmacology pmid:10529657
Yoh M et al. Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7. 1999 Can. J. Microbiol. pmid:10526400
Shortridge VD et al. Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995. 1999 Clin. Infect. Dis. pmid:10524961
Cocito C and Di Giambattista M The in vitro binding of virginiamycin M to bacteria ribosomes and ribosomal subunits. 1978 Mol. Gen. Genet. pmid:105240
Sheu BS et al. A three-day course of intravenous omeprazole plus antibiotics for H. pylori-positive bleeding duodenal ulcer. 1999 Jul-Aug Hepatogastroenterology pmid:10521999
Xue Q et al. A multiplasmid approach to preparing large libraries of polyketides. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10518520
De Winter BY et al. Effect of different prokinetic agents and a novel enterokinetic agent on postoperative ileus in rats. 1999 Gut pmid:10517907
Yoshida H and Furuta T [Tissue penetration properties of macrolide antibiotics--comparative tissue distribution of erythromycin-stearate, clarithromycin, roxithromycin and azithromycin in rats]. 1999 Jpn J Antibiot pmid:10516929
Chantarotorn S et al. Diffuse panbronchiolitis, the first case reports in Thailand. 1999 J Med Assoc Thai pmid:10511794
Ball SE et al. Population distribution and effects on drug metabolism of a genetic variant in the 5' promoter region of CYP3A4. 1999 Clin. Pharmacol. Ther. pmid:10511065
Kinirons MT et al. Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A. 1999 Clin. Pharmacol. Ther. pmid:10511057
McMullin ST et al. Impact of a Web-based clinical information system on cisapride drug interactions and patient safety. 1999 Arch. Intern. Med. pmid:10510994
Ahmad M et al. Disposition kinetics of erythromycin in normal and experimentally-induced febrile rabbits. 1999 Apr-Jun Eur J Drug Metab Pharmacokinet pmid:10510739
Khan SA et al. Simultaneous detection of erythromycin-resistant methylase genes ermA and ermC from Staphylococcus spp. by multiplex-PCR. 1999 Mol. Cell. Probes pmid:10508560
Oster P et al. Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates. 1999 Antimicrob. Agents Chemother. pmid:10508033
Miossec-Bartoli C et al. The new ketolide HMR3647 accumulates in the azurophil granules of human polymorphonuclear cells. 1999 Antimicrob. Agents Chemother. pmid:10508024
Rosendal K et al. Staphylococcus aureus strains isolated in Danish hospitals from January 1st, 1966, to December 31st, 1974. 1976 Acta Pathol Microbiol Scand B pmid:1050144
Widdowson CA and Klugman KP Molecular mechanisms of resistance to commonly used non-betalactam drugs in Streptococcus pneumoniae. 1999 Semin Respir Infect pmid:10501313
Moreno M et al. Clinical management of tacrolimus drug interactions in renal transplant patients. 1999 Transplant. Proc. pmid:10500564
Zgoulli S et al. Microencapsulation of erythromycin and clarithromycin using a spray-drying technique. 1999 Sep-Oct J Microencapsul pmid:10499837
Azuma A and Kudoh S [Diffuse panbronchiolitis: DPB]. 1999 Nippon Rinsho pmid:10497417
Gibson EM et al. Transfer of plasmid-mediated antibiotic resistance from streptococci to lactobacilli. 1979 J. Bacteriol. pmid:104973
Cash P et al. A proteomic analysis of erythromycin resistance in Streptococcus pneumoniae. 1999 Electrophoresis pmid:10493130
Moore PA Dental therapeutic indications for the newer long-acting macrolide antibiotics. 1999 J Am Dent Assoc pmid:10492541
Kirsten D and Meister W [Present possibilities of antibiotic therapy in chronic non-specific respiratory diseases (author's transl)]. 1976 Z Erkr Atmungsorgane pmid:1049185
Wieckiewicz JA Relationship between resistance to metallic ions and production of beta-lactamase in strains of Staphylococcus epidermidis. 1976 J Hyg Epidemiol Microbiol Immunol pmid:1048968
Gómez-Lus R et al. Is there an ecological relationship between rates of antibiotic resistance of species of the genus Streptococcus? The Spanish Surveillance Group for Respiratory Pathogens. 1999 J. Clin. Microbiol. pmid:10488213
Sarisuta N et al. Physico-chemical characterization of interactions between erythromycin and various film polymers. 1999 Int J Pharm pmid:10486428
Cizman M et al. Influence of increased macrolide consumption on macrolide resistance of common respiratory pathogens. 1999 Eur. J. Clin. Microbiol. Infect. Dis. pmid:10482034
Wilson DJ et al. Comparison of seven antibiotic treatments with no treatment for bacteriological efficacy against bovine mastitis pathogens. 1999 J. Dairy Sci. pmid:10480091
Howard KB et al. Azithromycin versus erythromycin for community-acquired pneumonia: a cost-minimization analysis. 1999 Am J Health Syst Pharm pmid:10478989
Gabriëls M et al. Densitometric thin layer chromatographic analysis of tretinoin and erythromycin in lotions for topical use in acne treatment. 1999 Eur J Pharm Biopharm pmid:10477329
Madinier IM et al. Resistance profile survey of 50 periodontal strains of Actinobacillus actinomyectomcomitans. 1999 J. Periodontol. pmid:10476896
Rizzo G et al. [Behavior of Vibrio cholerae strains of the biotype El Tor isolated in Apulia in 1973, in relation to various antibiotics and chemotherapeutics]. 1975 May-Jun Ann Sclavo pmid:1047628
Mikasa K et al. [Clinical application of the new action of macrolide preparations to respiratory diseases]. 1999 Nippon Naika Gakkai Zasshi pmid:10475020
Syphilis: CDC recommended treatment schedules 1976. 1976 Prim. Care pmid:1047450
Sturm A et al. Prokinetics in patients with gastroparesis: a systematic analysis. 1999 Sep-Oct Digestion pmid:10473966
Mikamo H et al. Adequate macrolide treatment schedules for uterine cervicitis caused by Chlamydia trachomatis. 1999 Sep-Oct Chemotherapy pmid:10473928
Sofer D et al. 'Subinhibitory' erythromycin represses production of Pseudomonas aeruginosa lectins, autoinducer and virulence factors. 1999 Sep-Oct Chemotherapy pmid:10473921
Nawaz MS et al. Biochemical and molecular characterization of erthromycin-resistant avian Staphylococcus spp. isolated from chickens. 1999 Poult. Sci. pmid:10472846